{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:52Z","timestamp":1772120032288,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82173613"],"award-info":[{"award-number":["82173613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Project of Shanghai Municipal Health Commission","award":["202140018"],"award-info":[{"award-number":["202140018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04104-8","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:59:17Z","timestamp":1732841957000},"page":"1090-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial and ethnic disparities in the risk of second primary malignancies in differentiated thyroid cancer patients: a population-based study"],"prefix":"10.1007","volume":"87","author":[{"given":"Xingling","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"1","key":"4104_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101703","volume":"37","author":"L Valerio","year":"2023","unstructured":"L. Valerio, F. Maino, M.G. Castagna, F. Pacini, Radioiodine therapy in the different stages of differentiated thyroid cancer. Best. Pr. Res Clin. Endocrinol. Metab. 37(1), 101703 (2023). https:\/\/doi.org\/10.1016\/j.beem.2022.101703","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"4104_CR2","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.2147\/cmar.S198514","volume":"11","author":"K Kaliszewski","year":"2019","unstructured":"K. Kaliszewski, Does every classical type of well-differentiated thyroid cancer have excellent prognosis? A case series and literature review. Cancer Manag Res 11, 2441\u20132448 (2019). https:\/\/doi.org\/10.2147\/cmar.S198514","journal-title":"Cancer Manag Res"},{"issue":"18","key":"4104_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2017.0562","volume":"317","author":"JS Lin","year":"2017","unstructured":"J.S. Lin, E.J.A. Bowles, S.B. Williams, C.C. Morrison, Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 317(18), 1888\u20131903 (2017). https:\/\/doi.org\/10.1001\/jama.2017.0562","journal-title":"JAMA"},{"issue":"11","key":"4104_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/0284186x.2016.1196829","volume":"55","author":"D Uprety","year":"2016","unstructured":"D. Uprety, A. Khanal, L. Arjyal et al. The risk of secondary primary malignancy in early stage differentiated thyroid cancer: a US population-based study. Acta Oncol. 55(11), 1375\u20131377 (2016). https:\/\/doi.org\/10.1080\/0284186x.2016.1196829","journal-title":"Acta Oncol."},{"issue":"13","key":"4104_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1200\/jco.21.01841","volume":"40","author":"E Pasqual","year":"2022","unstructured":"E. Pasqual, S. Schonfeld, L.M. Morton et al. Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies. J. Clin. Oncol. 40(13), 1439\u20131449 (2022). https:\/\/doi.org\/10.1200\/jco.21.01841","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"4104_CR6","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1200\/jco.2012.41.8681","volume":"30","author":"ME Wood","year":"2012","unstructured":"M.E. Wood, V. Vogel, A. Ng, L. Foxhall, P. Goodwin, L.B. Travis, Second malignant neoplasms: assessment and strategies for risk reduction. J. Clin. Oncol. 30(30), 3734\u20133745 (2012). https:\/\/doi.org\/10.1200\/jco.2012.41.8681","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"4104_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/thy.2016.0626","volume":"27","author":"SA Shah","year":"2017","unstructured":"S.A. Shah, M.A. Adam, S.M. Thomas et al. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap? Thyroid 27(6), 762\u2013772 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0626","journal-title":"Thyroid"},{"issue":"5","key":"4104_CR8","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1245\/s10434-023-13158-3","volume":"30","author":"SP Ginzberg","year":"2023","unstructured":"S.P. Ginzberg, J.M. Soegaard Ballester, C.J. Wirtalla et al. Racial and Ethnic Disparities in Appropriate Thyroid Cancer Treatment, Before and After the Release of the 2015 American Thyroid Association Guidelines. Ann. Surg. Oncol. 30(5), 2928\u20132937 (2023). https:\/\/doi.org\/10.1245\/s10434-023-13158-3","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"4104_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/thy.2022.0432","volume":"33","author":"S Davis","year":"2023","unstructured":"S. Davis, T.M. Ullmann, S. Roman, Disparities in Treatment for Differentiated Thyroid Cancer. Thyroid 33(3), 287\u2013293 (2023). https:\/\/doi.org\/10.1089\/thy.2022.0432","journal-title":"Thyroid"},{"issue":"19","key":"4104_CR10","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/jama.2023.5965","volume":"329","author":"TA LaVeist","year":"2023","unstructured":"T.A. LaVeist, E.J. P\u00e9rez-Stable, P. Richard et al. The Economic Burden of Racial, Ethnic, and Educational Health Inequities in the US. JAMA 329(19), 1682\u20131692 (2023). https:\/\/doi.org\/10.1001\/jama.2023.5965","journal-title":"JAMA"},{"key":"4104_CR11","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1017\/s2045796023000690","volume":"32","author":"Y Jiang","year":"2023","unstructured":"Y. Jiang, Y. Wang, X. Cheng et al. Suicide rates among patients with first and second primary cancer. Epidemiol. Psychiatr. Sci. 32, e57 (2023). https:\/\/doi.org\/10.1017\/s2045796023000690","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"4104_CR12","doi-asserted-by":"publisher","unstructured":"D.J. Moke, Z. Song, L. Liu, A.S. Hamilton, D. Deapen, D.R. Freyer. A Population-Based Analysis of 30-Year Mortality among Five-Year Survivors of Adolescent and Young Adult Cancer: The Roles of Primary Cancer, Subsequent Malignancy, and Other Health Conditions. Cancers. 13(16) (2021). https:\/\/doi.org\/10.3390\/cancers13163956","DOI":"10.3390\/cancers13163956"},{"issue":"3","key":"4104_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","volume":"17","author":"M Schlumberger","year":"2021","unstructured":"M. Schlumberger, S. Leboulleux, Current practice in patients with differentiated thyroid cancer. Nat. Rev. Endocrinol. 17(3), 176\u2013188 (2021). https:\/\/doi.org\/10.1038\/s41574-020-00448-z","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"4104_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00535-014-1026-z","volume":"50","author":"K Hanada","year":"2015","unstructured":"K. Hanada, A. Okazaki, N. Hirano et al. Diagnostic strategies for early pancreatic cancer. J. Gastroenterol. 50(2), 147\u2013154 (2015). https:\/\/doi.org\/10.1007\/s00535-014-1026-z","journal-title":"J. Gastroenterol."},{"issue":"9719","key":"4104_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/s0140-6736(10)60353-4","volume":"375","author":"D Cunningham","year":"2010","unstructured":"D. Cunningham, W. Atkin, H.J. Lenz et al. Colorectal cancer. Lancet 375(9719), 1030\u20131047 (2010). https:\/\/doi.org\/10.1016\/s0140-6736(10)60353-4","journal-title":"Lancet"},{"key":"4104_CR16","unstructured":"SEER. Seer*Stat databases: November 2022 submission, (2022). https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2022\/"},{"key":"4104_CR17","unstructured":"Surveillance, Epidemiology, and end results program. SEER, (2022). https:\/\/seer.cancer.gov\/index.html"},{"key":"4104_CR18","unstructured":"Institute NC, Health USNIo. Surveillance Epidemiology and End Results: ICD-O-3 Coding Materials, (2022). https:\/\/seer.cancer.gov\/icd-o-3\/"},{"issue":"13","key":"4104_CR19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. Jama 317(13), 1338\u20131348 (2017). https:\/\/doi.org\/10.1001\/jama.2017.2719","journal-title":"Jama"},{"issue":"5","key":"4104_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40618-022-01949-6","volume":"46","author":"X Wang","year":"2023","unstructured":"X. Wang, X. Zheng, J. Zhu, Z. Li, T. Wei, A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study. J. Endocrinol. Invest 46(5), 893\u2013901 (2023). https:\/\/doi.org\/10.1007\/s40618-022-01949-6","journal-title":"J. Endocrinol. Invest"},{"key":"4104_CR21","first-page":"307","volume":"14","author":"WG Report","year":"2005","unstructured":"W.G. Report, International rules for multiple primary cancers (ICD-0 third edition). Eur. J. Cancer Prev. J. Eur. Cancer Prev. Organ ECP 14, 307\u2013308 (2005)","journal-title":"Eur. J. Cancer Prev. J. Eur. Cancer Prev. Organ ECP"},{"issue":"5","key":"4104_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2011.0406","volume":"23","author":"C Kim","year":"2013","unstructured":"C. Kim, X. Bi, D. Pan et al. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23(5), 575\u2013582 (2013). https:\/\/doi.org\/10.1089\/thy.2011.0406","journal-title":"Thyroid"},{"issue":"24","key":"4104_CR23","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"H. Sung, N. Hyun, C.R. Leach, K.R. Yabroff, A. Jemal, Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States. JAMA 324(24), 2521\u20132535 (2020). https:\/\/doi.org\/10.1001\/jama.2020.23130","journal-title":"JAMA"},{"issue":"16","key":"4104_CR24","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.7150\/jca.44581","volume":"11","author":"B Ma","year":"2020","unstructured":"B. Ma, G. Qin, Y. Zhang, C. Su, Z. Wu, Life-long follow-up of second primary lung and extra-pulmonary cancer in lung cancer patients is needed. J. Cancer 11(16), 4709\u20134715 (2020). https:\/\/doi.org\/10.7150\/jca.44581","journal-title":"J. Cancer"},{"issue":"2","key":"4104_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/aje\/kwp107","volume":"170","author":"B Lau","year":"2009","unstructured":"B. Lau, S.R. Cole, S.J. Gange, Competing risk regression models for epidemiologic data. Am. J. Epidemiol. 170(2), 244\u2013256 (2009). https:\/\/doi.org\/10.1093\/aje\/kwp107","journal-title":"Am. J. Epidemiol."},{"key":"4104_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jclinepi.2015.07.006","volume":"69","author":"C van Walraven","year":"2016","unstructured":"C. van Walraven, F.A. McAlister, Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals. J. Clin. Epidemiol. 69, 170\u20133.e8 (2016). https:\/\/doi.org\/10.1016\/j.jclinepi.2015.07.006","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"4104_CR27","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/ede.0000000000001378","volume":"32","author":"B Shi","year":"2021","unstructured":"B. Shi, C. Choirat, B.A. Coull, T.J. VanderWeele, L. Valeri, CMAverse: A Suite of Functions for Reproducible Causal Mediation Analyses. Epidemiology 32(5), e20\u2013e22 (2021). https:\/\/doi.org\/10.1097\/ede.0000000000001378","journal-title":"Epidemiology"},{"issue":"20","key":"4104_CR28","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1200\/jco.2014.57.1349","volume":"33","author":"ET Warner","year":"2015","unstructured":"E.T. Warner, R.M. Tamimi, M.E. Hughes et al. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. J. Clin. Oncol. 33(20), 2254\u20132261 (2015). https:\/\/doi.org\/10.1200\/jco.2014.57.1349","journal-title":"J. Clin. Oncol."},{"issue":"10439","key":"4104_CR29","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/s0140-6736(24)00747-5","volume":"403","author":"CE Coles","year":"2024","unstructured":"C.E. Coles, H. Earl, B.O. Anderson et al. The Lancet Breast Cancer Commission. Lancet 403(10439), 1895\u20131950 (2024). https:\/\/doi.org\/10.1016\/s0140-6736(24)00747-5","journal-title":"Lancet"},{"issue":"9","key":"4104_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41574-018-0068-3","volume":"14","author":"L Lamartina","year":"2018","unstructured":"L. Lamartina, G. Grani, C. Durante, I. Borget, S. Filetti, M. Schlumberger, Follow-up of differentiated thyroid cancer - what should (and what should not) be done. Nat. Rev. Endocrinol. 14(9), 538\u2013551 (2018). https:\/\/doi.org\/10.1038\/s41574-018-0068-3","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"4104_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"3","key":"4104_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s13187-015-0853-9","volume":"31","author":"CJ Berg","year":"2016","unstructured":"C.J. Berg, E. Stratton, N. Esiashvili, A. Mertens, Young Adult Cancer Survivors\u2019 Experience with Cancer Treatment and Follow-Up Care and Perceptions of Barriers to Engaging in Recommended Care. J. Cancer Educ. 31(3), 430\u2013442 (2016). https:\/\/doi.org\/10.1007\/s13187-015-0853-9","journal-title":"J. Cancer Educ."},{"key":"4104_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-256","volume":"10","author":"T Salz","year":"2010","unstructured":"T. Salz, M. Weinberger, J.Z. Ayanian et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv. Res. 10, 256 (2010). https:\/\/doi.org\/10.1186\/1472-6963-10-256","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"4104_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11764-021-01046-2","volume":"16","author":"P Advani","year":"2022","unstructured":"P. Advani, S. Advani, P. Nayak et al. Racial\/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. J. Cancer Surviv. 16(3), 514\u2013530 (2022). https:\/\/doi.org\/10.1007\/s11764-021-01046-2","journal-title":"J. Cancer Surviv."},{"issue":"3","key":"4104_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.21873\/anticanres.15605","volume":"42","author":"MC Jin","year":"2022","unstructured":"M.C. Jin, Z.J. Qian, U.C. Megwalu, Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer. Anticancer Res. 42(3), 1359\u20131365 (2022). https:\/\/doi.org\/10.21873\/anticanres.15605","journal-title":"Anticancer Res."},{"issue":"1","key":"4104_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0360-3016(03)00073-7","volume":"56","author":"EJ Hall","year":"2003","unstructured":"E.J. Hall, C.S. Wuu, Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J. Radiat. Oncol. Biol. Phys. 56(1), 83\u201388 (2003). https:\/\/doi.org\/10.1016\/s0360-3016(03)00073-7","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"25","key":"4104_CR37","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1200\/jco.2005.02.543","volume":"23","author":"H Birgisson","year":"2005","unstructured":"H. Birgisson, L. P\u00e5hlman, U. Gunnarsson, B. Glimelius, Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J. Clin. Oncol. 23(25), 6126\u20136131 (2005). https:\/\/doi.org\/10.1200\/jco.2005.02.543","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"4104_CR38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","volume":"89","author":"C Rubino","year":"2003","unstructured":"C. Rubino, F. de Vathaire, M.E. Dottorini et al. Second primary malignancies in thyroid cancer patients. Br. J. Cancer 89(9), 1638\u20131644 (2003). https:\/\/doi.org\/10.1038\/sj.bjc.6601319","journal-title":"Br. J. Cancer"},{"issue":"3","key":"4104_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-013-2816-3","volume":"143","author":"HS Wirtz","year":"2014","unstructured":"H.S. Wirtz, D.M. Boudreau, J.R. Gralow et al. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res. Treat. 143(3), 541\u2013550 (2014). https:\/\/doi.org\/10.1007\/s10549-013-2816-3","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"4104_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3322\/caac.21718","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"A.N. Giaquinto, K.D. Miller, K.Y. Tossas, R.A. Winn, A. Jemal, R.L. Siegel, Cancer statistics for African American\/Black People 2022. CA Cancer J. Clin. 72(3), 202\u2013229 (2022). https:\/\/doi.org\/10.3322\/caac.21718","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"4104_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.amjsurg.2022.09.041","volume":"225","author":"MK Luff","year":"2023","unstructured":"M.K. Luff, J. Kim, C.H. Tseng, M.J. Livhits, M.W. Yeh, J.X. Wu, Racial\/ethnic disparities in thyroid cancer in California, 1999-2017. Am. J. Surg. 225(2), 298\u2013303 (2023). https:\/\/doi.org\/10.1016\/j.amjsurg.2022.09.041","journal-title":"Am. J. Surg."},{"issue":"1","key":"4104_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/s0022215116009737","volume":"131","author":"UC Megwalu","year":"2017","unstructured":"U.C. Megwalu, A.T. Saini, Racial disparities in papillary thyroid microcarcinoma survival. J. Laryngol. Otol. 131(1), 83\u201387 (2017). https:\/\/doi.org\/10.1017\/s0022215116009737","journal-title":"J. Laryngol. Otol."},{"issue":"1","key":"4104_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/jco.2017.74.2049","volume":"36","author":"L Ellis","year":"2018","unstructured":"L. Ellis, A.J. Canchola, D. Spiegel, U. Ladabaum, R. Haile, S.L. Gomez, Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J. Clin. Oncol. 36(1), 25\u201333 (2018). https:\/\/doi.org\/10.1200\/jco.2017.74.2049","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"4104_CR44","doi-asserted-by":"publisher","first-page":"e2327429","DOI":"10.1001\/jamanetworkopen.2023.27429","volume":"6","author":"H Sung","year":"2023","unstructured":"H. Sung, L. Nisotel, E. Sedeta, F. Islami, A. Jemal, Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US. JAMA Netw. Open 6(8), e2327429 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.27429","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"4104_CR45","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.7150\/jca.52329","volume":"12","author":"Y Li","year":"2021","unstructured":"Y. Li, D. Huang, B. Wang, W. Mao, X. Chen, P. Dong, Socioeconomic factors are associated with the prognosis of Thyroid Cancer. J. Cancer 12(9), 2507\u20132512 (2021). https:\/\/doi.org\/10.7150\/jca.52329","journal-title":"J. Cancer"},{"issue":"1","key":"4104_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"R.L. Siegel, K.D. Miller, N.S. Wagle, A. Jemal, Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17\u201348 (2023). https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"4104_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncr.29025","volume":"121","author":"YY Cho","year":"2015","unstructured":"Y.Y. Cho, J. Lim, C.M. Oh et al. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea. Cancer 121(2), 259\u2013268 (2015). https:\/\/doi.org\/10.1002\/cncr.29025","journal-title":"Cancer"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04104-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:22:45Z","timestamp":1740129765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04104-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4104"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04104-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5032737\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}